Good Neighbor Pharmacy® Named #1 in Customer Satisfaction with Chain Drug Store Pharmacies by J.D. Power for 8th Consecutive Year
31 Julio 2024 - 7:30AM
Business Wire
Good Neighbor Pharmacy received top scores in
all study dimensions, including ‘level of trust with pharmacy’
Good Neighbor Pharmacy (GNP), a national franchise for
independent pharmacies offered through Cencora, announced that it
has been ranked “#1 in Customer Satisfaction with Chain Drug Store
Pharmacies” in the J.D. Power 2024 U.S. Pharmacy StudySM. This is
the 13th time that Good Neighbor Pharmacy has earned this
recognition in the last 15 years and marks the network’s eighth
consecutive win.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240731497360/en/
“I’d like to extend my sincere congratulations to our Good
Neighbor Pharmacy members on receiving this prestigious recognition
from J.D. Power for the eighth consecutive year,” said Jenni Zilka,
SVP, Community & Specialty Pharmacy and President of Good
Neighbor Pharmacy. “This feat reflects our member pharmacies’
unwavering dedication to putting their patients first and
delivering exceptional care every day. It is a privilege to stand
alongside them as they demonstrate the power of pharmacies as
accessible destinations for high-touch, high-quality care, and an
honor to say that no one does it better than the Good Neighbor
Pharmacy network.”
The J.D. Power 2024 U.S. Pharmacy Study implements a modular
approach in which respondents complete a core set of questions
addressing seven dimensions that represent distinct parts of the
customer experience. In addition to receiving #1 in Chain Drug
Store Pharmacy Customer Satisfaction overall, Good Neighbor
Pharmacy ranked #1 across all seven core dimensions,
specifically:
- Pharmacy offerings meet my needs
- Resolving problems or complaints
- Able to get prescriptions how/when I want
- Digital channels – website, mobile app, text
- People
- Helping to save me time or money
- My level of trust with pharmacy
“This recognition truly belongs to our Good Neighbor Pharmacy
members, as the results of J.D. Power’s study are a testament to
their commitment to serving their communities,” said Tim Cernohous,
SVP & President, Community, Retail and Long-Term Care Pharmacy
at Cencora. “As patients seek out pharmacies for care services
beyond dispensing medications, pharmacists are navigating the
opportunities and challenges that come with those expectations. Our
Good Neighbor Pharmacy members have a deep reach into, and close
relationships with, their communities. This, combined with their
clinical background, has allowed them to organically step into an
expanded role to meet the growing needs of their patients. We are
honored to work side by side with our Good Neighbor Pharmacy
members, ensuring that they have the resources needed to continue
serving their communities while paving the path of independent
pharmacy forward.”
The J.D. Power U.S. Pharmacy Study, now in its 15th year, is a
syndicated benchmarking study profiling the experiences of
customers from the largest pharmacies in the United States. The
2024 study is based on responses from 13,505 U.S. pharmacy
customers who filled a prescription in the last 12 months prior to
the survey period of September 2023 to May 2024.
To learn more about Good Neighbor Pharmacy, visit
https://www.wearegnp.com/. Learn more about J.D. Power at
http://jdpower.com/awards.
About Cencora
Cencora is a leading global pharmaceutical solutions
organization centered on improving the lives of people and animals
around the world. We partner with pharmaceutical innovators across
the value chain to facilitate and optimize market access to
therapies. Care providers depend on us for the secure, reliable
delivery of pharmaceuticals, healthcare products, and solutions.
Our 46,000+ worldwide team members contribute to positive health
outcomes through the power of our purpose: We are united in our
responsibility to create healthier futures. Cencora is ranked #10
on the Fortune 500 and #24 on the Global Fortune 500 with more than
$250 billion in annual revenue. Learn more at
investor.cencora.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240731497360/en/
Mackenzie Liberatori 267.252.5704
Mackenzie.Liberatori@cencora.com